News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment…
Family planning is an important issue for the CML patients of childbearing potential, because they…
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…
The New England Journal of Medicine recently published the primary endpoint of the NRG Oncology clinical…
Chemotherapy for non-Hodgkin’s lymphomas is highly effective for most patients. In aggressive lymphomas, such as…
T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive cancer which is lethal to 15% of…
Multiple myeloma is the second most common haematological cancer, and despite significant progress in the…
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed…
A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case…
New information about adjuvant therapy to prevent recurrence of breast cancer in women 50 years…